However, no significant correlations were observed between SNX17 expression and other clinicopathological factors including age, tumor size, TNM grade, cirrhosis status, serum alpha-fetoprotein (AFP) level, vessel carcinoma embolus (VCE), HBV positivity status, portal vein tumor thrombus (PVTT) and vessel carcinoma embolus (VCE), capsule status (Supplementary Table S5). This evidence concerns the gene SNX17 and neoplasm.